Search Login Register

troglitazone (Rezulin) Summary

661 relevant articles (84 outcomes, 142 trials/studies) found for this Drug

Description: induces solid tumor differentiation; structure given in first source; withdrawn from the market by manufacturer; PPAR agonist used for type II diabetes

Also Known As: Rezulin; Prelay; 5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione); CS 045; CS-045 Show All >>

Key Diseases for which troglitazone is Relevant

  1. Insulin Resistance : 23 outcomes 15 studies in 133 results
  2. Type 2 Diabetes Mellitus (MODY) : 14 outcomes 27 studies in 111 results
  3. Hyperinsulinism (Hyperinsulinemia) : 9 outcomes 3 studies in 33 results
  4. Hyperglycemia : 8 outcomes 1 study in 28 results
  5. Hypertension (High Blood Pressure) : 4 outcomes 3 studies in 15 results
Show All >>

Drugs Related to troglitazone

  1. Insulin (Novolin)
  2. Glucose (Dextrose)
  3. PPAR gamma
  4. Metformin (Glucophage)
  5. Thiazolidinediones
  6. 2,4-thiazolidinedione (thiazolidinedione)
  7. pioglitazone (Actos)
  8. rosiglitazone (Avandia)
  9. Acarbose
  10. Leptin
Show All >>

Therapies Related to troglitazone

  1. Heterologous Transplantation (Xenotransplantation)
  2. Amputation
  3. Stents
  4. Drug Therapy (Chemotherapy)
  5. Liver Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.